Literature DB >> 27083238

Novel autologous T-cell therapy for drug-resistant cytomegalovirus disease after lung transplantation.

Paola Pierucci1, Monique Malouf1, Allan R Glanville1, Leone Beagley2, Corey Smith3, Rajiv Khanna3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27083238     DOI： 10.1016/j.healun.2015.12.031

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  5 in total

1.  T cell repertoire remodeling following post-transplant T cell therapy coincides with clinical response.

Authors:  Corey Smith; Dillon Corvino; Leone Beagley; Sweera Rehan; Michelle A Neller; Pauline Crooks; Katherine K Matthews; Matthew Solomon; Laetitia Le Texier; Scott Campbell; Ross S Francis; Daniel Chambers; Rajiv Khanna
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

Review 2.  CMV Prevention and Treatment in Transplantation: What's New in 2019.

Authors:  Anat Stern; Genovefa A Papanicolaou
Journal:  Curr Infect Dis Rep       Date:  2019-11-15       Impact factor: 3.725

Review 3.  Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?

Authors:  Estéfani García-Ríos; Marcos Nuévalos; Francisco J Mancebo; Pilar Pérez-Romero
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 4.  The CD4+ T Cell Response to Human Cytomegalovirus in Healthy and Immunocompromised People.

Authors:  Eleanor Y Lim; Sarah E Jackson; Mark R Wills
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

Review 5.  Clinical and biological insights from viral genome sequencing.

Authors:  Charlotte J Houldcroft; Mathew A Beale; Judith Breuer
Journal:  Nat Rev Microbiol       Date:  2017-01-16       Impact factor: 60.633
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.